LGC Clinical Diagnostics Blog

Continued Advances in NIPT Drives Updated Recommendations

Our 2020 blog, Evolution of non-invasive prenatal testing (NIPT), discussed the testing’s history...

Improving When & How Rheumatoid Arthritis is Diagnosed

Nearly 20 million people worldwide live with rheumatoid arthritis (RA), making it one of the most...

When a Bad Repair Leads to a Happy Ending: Homologous Recombination Deficiency Assays for Guiding Anti-Cancer Therapies

Genome instability - in which tumor cells sustain elevated frequencies of chromosomal lesions - is...

Optimal Reference Materials for Evolving Oncology Testing

Targeted therapies are dramatically improving cancer treatment. Next-generation sequencing (NGS)...

5 Best Practices for Best-in-class Clinical Lab Quality Control

Reliability and reproducibility in a clinical lab are paramount. So is preventing (or at least...

Virus-like particles – the new candidate of choice for diagnosing and preventing rubella

Infectious diseases are becoming increasingly difficult to manage in the modern medical landscape....

Are your BRCA1/2 tests sufficient?

Breast cancer susceptibility genes 1 and 2 (BRCA1 and BRCA2) encode proteins functioning as tumor...

Understanding the Essentials of Medical Laboratory Quality Control

“Quality is achieved by doing the right thing right the first and every time. The most important...

How Labs Prepare for a Pandemic - Webinar Overview

When the FDA issued a COVID-19 emergency use authorization (EUA) in 2020, Dr. Jeff SoRelIe was...

Tick-born encephalopathy virus (TBEV) resurgence and increased diagnostic surveillance

Tick-born encephalopathy cases in Europe have increased exponentially over the last decade. As a...